Compare DSX & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSX | RXST |
|---|---|---|
| Founded | 1999 | 1997 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.7M | 305.0M |
| IPO Year | N/A | 2021 |
| Metric | DSX | RXST |
|---|---|---|
| Price | $2.48 | $6.37 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $11.60 |
| AVG Volume (30 Days) | ★ 931.3K | 612.2K |
| Earning Date | 02-26-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.73% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $134,479,000.00 |
| Revenue This Year | $14.28 | N/A |
| Revenue Next Year | $4.87 | $9.57 |
| P/E Ratio | $16.02 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.27 | $6.35 |
| 52 Week High | $2.72 | $27.13 |
| Indicator | DSX | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 29.30 |
| Support Level | $2.26 | N/A |
| Resistance Level | $2.72 | $9.11 |
| Average True Range (ATR) | 0.13 | 0.41 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 54.32 | 17.96 |
Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.